ACYP2 Activators
ACYP2 activators encompass a range of compounds that indirectly influence the activity of ACYP2 through various signaling pathways and cellular processes. The first group of activators includes agents that increase the levels of second messengers such as cAMP and cGMP. Forskolin, by elevating cAMP, and Zaprinast, through enhancing cGMP, both indirectly promote the activation of ACYP2 by stimulating protein kinases like PKA and PKG that can phosphorylate proteins in proximity to or involved with ACYP2. These phosphorylation events can lead to a cascade of intracellular reactions that ultimately increase the functional activity of ACYP2. By promoting the phosphorylation of proteins that interact with ACYP2, these kinases may change the conformational state of ACYP2 or its interacting partners, enhancing its catalytic efficiency. Moreover, the elevated levels of cAMP and cGMP can also lead to the activation of other signaling molecules and transcription factors, which might upregulate the expression of ACYP2 or its substrates, further potentiating its activity within the cell.
In addition to these second messenger system modulators, other types of ACYP2 activators function by inhibiting kinases and phosphatases that play a role in the regulation of ACYP2 activity. Compounds such as LY294002 and PD98059, which inhibit PI3K and MEK respectively, can shift the phosphorylation equilibrium in the cell, potentially leading to a higher proportion of dephosphorylated ACYP2, which may be the more active form. Similarly, inhibitors of protein kinase C, such as Gö6983, or Ca2+/calmodulin-dependent protein kinase II, such as KN-93, may indirectly increase ACYP2 activity by preventing phosphorylation-dependent inhibitory effects on ACYP2 or its associated regulatory proteins. These intricate, interconnected pathways highlight the complexity of cellular regulation and the potential for pharmacological intervention to modulate enzyme activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP activates PKA, which can phosphorylate target proteins, potentially enhancing ACYP2 activity by increasing its substrate availability. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases cAMP and cGMP by preventing their degradation. Higher cAMP/cGMP levels may result in a similar PKA-mediated phosphorylation cascade as Forskolin, influencing ACYP2 indirectly. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can lead to phosphorylation events that may increase ACYP2’s activity by modifying its interaction with other cellular proteins. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. This could enhance ACYP2 activity by affecting its phosphorylation state indirectly. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels which can activate calcium-dependent signaling pathways, potentially influencing ACYP2 by altering its substrate or enzyme interaction dynamics. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, potentially affecting ACYP2 activity indirectly through calcium-mediated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium concentration, potentially modifying ACYP2 activity through calcium-dependent protein phosphorylation or dephosphorylation pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which could lead to altered phosphorylation states of proteins that may interact with ACYP2, indirectly modulating its activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, similar to okadaic acid, leading to enhanced phosphorylation within the cell, potentially affecting ACYP2's regulation or interaction with phospho-proteins. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that might affect ACYP2 by altering phosphorylation cascades, possibly leading to changes in its activity or the activity of proteins that regulate ACYP2. | ||||||